Bridger Management, LLC Amneal Pharmaceuticals, Inc. Transaction History

Bridger Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $12.1 Million - $15.2 Million	-1,021,420 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $21.2 Million - $34.8 Million	-1,621,201 Reduced 61.35%	1,021,420 $13.8 Million
Q3 2018 Nov 14, 2018	BUY	$16.4 - $24.27 $8.18 Million - $12.1 Million	499,000 Added 23.28%	2,642,621 $58.6 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $29.9 Million - $43.3 Million	2,143,621 New	2,143,621 $35.2 Million

187

137M

234K

45.9K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.29B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridger Management, LLC with notifications on news.